IMTH (Innovative MedTech) Tariff Resilience Score : 5/10 (As of Jul. 16, 2025)

View and export this data going back to 2007. Start your Free Trial

What is Innovative MedTech Tariff Resilience Score?

Innovative MedTech has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Innovative MedTech has Innovative MedTech has moderate exposure to tariffs due to its reliance on imported medical devices. However, its focus on the U.S. market and potential for alternative suppliers provide some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Innovative MedTech might have Average Resilient.

Competitive Comparison of Innovative MedTech's Tariff Resilience Score

For the Medical Instruments & Supplies subindustry, Innovative MedTech's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative MedTech's Tariff Resilience Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative MedTech's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Innovative MedTech's Tariff Resilience Score falls into.

Save Embed

;

Save Embed

;

Innovative MedTech (OTCPK:IMTH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score	Resilience Level
7 - 10	Highly Resilient
4 - 6	Average Resilient
0 - 3	Highly Vulnerable

Innovative MedTech Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Innovative MedTech's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative MedTech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative MedTech Inc (OTCPK:IMTH) » Definitions » Tariff Resilience Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

2310 York Street, Suite 200, Blue Island, IL, USA, 60406

Website

https://www.innovativemedtech.com

Innovative MedTech Inc is a provider of health and wellness services. It develops, manufactures, and sells a variety of medical devices and supplies, including blood collection and infusion products, surgical instruments, and wound care products. The company operates in two divisions: technology and devices and Adult Day Services.

Executives

Merle Griff	officer: Chief Executive Officer	2310 YORK ST, SUITE 200, BLUE ISLAND IL 60406
Eddie Dovner	10 percent owner	70 SE 4TH AVE, DELRAY BEACH FL 33483
Charles Everhardt	director, 10 percent owner, other: Chairman of the Board	2310 YORK ST, STE 200, BLUE ISLAND IL 60406
Arthur Friedman	10 percent owner	280 MADISON AVE #1007, NEW YORK NY 10016
Marcia Roberts	10 percent owner	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Michael Jordan Friedman	director, 10 percent owner, officer: President & CEO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Illuminate, Inc.	10 percent owner	881 KENNEDY BLVD., JERSEY CITL NJ 07002
A William Bodine	director, officer: CFO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Dominick M Cingari	director, officer: COO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Jay Odintz	director	280 MADISON AVENUE, NEW YORK NY 10016
Vincent L Verdiramo	director, officer: President	3163 KENNEDY BLVD, JERSEY CITY NJ 07306